0001209191-20-026615.txt : 20200501
0001209191-20-026615.hdr.sgml : 20200501
20200501180012
ACCESSION NUMBER: 0001209191-20-026615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200429
FILED AS OF DATE: 20200501
DATE AS OF CHANGE: 20200501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ridloff Elena
CENTRAL INDEX KEY: 0001772518
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 20842131
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-29
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001772518
Ridloff Elena
C/O ACADIA PHARMACEUTICALS INC.
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO
CA
92130
0
1
0
0
EVP and CFO
Common Stock
2020-04-29
4
M
0
10000
25.12
A
10000
D
Common Stock
2020-04-29
4
S
0
10000
50.7353
D
0
D
Common Stock
2020-04-29
4
M
0
3245
A
3245
D
Common Stock
2020-04-30
4
S
0
1050
49.22
D
2195
D
Stock Option (Right to Buy)
25.12
2020-04-29
4
M
0
10000
0.00
D
2029-04-29
Common Stock
10000
35547
D
Restricted Stock Units
2020-04-29
4
M
0
3245
0.00
D
Common Stock
3245
9736
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $51.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
25% of the 45,547 shares originally subject to the stock option vested and became exercisable on April 29, 2020, and the remaining shares vest in 36 equal monthly installments thereafter.
The restricted stock units vest in four equal annual installments beginning 4/29/2020.
/s/ Austin D. Kim, Attorney-in-Fact
2020-05-01